News & Media

21 January 2025

A study led by Dr Alan Prem Kumar, a member of N2CR, delves into how cancer arises from disruptions in cell cycle regula...

17 January 2025

Gastric cancer (GC) has significant global mortality with high heterogeneity. A study of 226 GC samples from 121 patient...

15 January 2025

The tumour microenvironment (TME) plays a pivotal role in cancer progression, metastasis, and therapeutic resistance. Co...

12 January 2025

Research led by N2CR member Dr. Cheok Chit Fang found that the tumour suppressor protein p53 protects DNA during replica...

12 January 2025

Gold nanoparticles (NPs) are promising for cancer therapy due to their versatile properties. However, their interactions...

6 December 2024

CIITA is the master regulator of MHC class-II immune genes that are important for defense mechanism against infections a...

25 November 2024

Chemotherapy, although the first line of defense in cancer treatment, is indiscriminate and is damaging to the entire bo...

18 November 2024

This research, led by N2CR members Prof Goh Boon Cher and Prof Shazib Pervaiz with Dr Jayshree Hirpara as the first auth...

4 November 2024

Detecting cancer-driving mutations is crucial for understanding cancer and developing treatments. Existing prediction to...